Table 3 Comparing management in subjects with and without liver metastasis

Peritoneal carcinomatosis

 Diuretics

15/73 (20.5%)

16/77 (21%)

1

 Paracentesis

11/73 (15%)

24/77 (31%)

0.02

 Peritoneal drain

16/73 (22%)

15/77 (19%)

0.8

 Shunt

1/73 (1.4%)

0/77(0%)

0.5

 Chemotherapy/Immunotherapy*

30/73 (41%)

22/77 (28.5%)

0.1

Portal hypertension

 Diuretics

4/39 (10%)

4/30 (13%)

0.7

 Paracentesis

7/39 (18%)

11/30 (37%)

0.1

 Peritoneal drain

18/39 (46%)

2/30 (7%)

 < 0.001

 Shunt

0/39 (0%)

0/30 (0%)

1

 Chemotherapy/Immunotherapy*

10/39 (26%)

13/30 (43%)

0.1

Sinusoidal portal hypertension

 Diuretics

0/4 (0%)

0/9 (0%)

1

 Paracentesis

1/4 (25%)

3/9 (33%)

1

 Peritoneal drain

2/4 (50%)

1/9 (11%)

0.2

 Shunt

0/4 (0%)

0/9 (0%)

1

 Chemotherapy/Immunotherapy*

1/4 (25%)

5/9 (55.5%)

0.6